Navigation Links
UM researcher develops new way to assess risk for chemicals
Date:12/21/2011

CORAL GABLES, FL Approximately 80,000 industrial chemicals are in use and about 700 new chemicals are introduced to commerce each year in the United States, according to the U.S. Government Accountability Office. To assess human health risks from exposure to harmful substances, James Englehardt, professor in the College of Engineering at the University of Miami, is proposing a new technique that is more efficient than current methods.

The new model reduces the data requirements 21-fold from previous models, and can predict the likelihood of illness not just from exposure to individual substances, but also from chemical mixtures. The findings are published online in advance of print, by the journal of Risk Analysis.

"The method we are proposing could be applied, for example, to drinking water containing chemical byproducts of chlorine disinfection; well water contaminated with chemicals spilled or released to the subsurface; polluted indoor or outdoor air; or food contaminated with pesticides or other chemicals," says Englehardt, principal investigator of this project.

In general, chemical contaminants do not occur individually, but rather in mixtures, and components of the mixtures can act to increase, or reduce the health effects of other mixture components, explained Englehardt.

"Previously, no generally-accepted dose-response function was known for mixtures," Englehardt says. "I therefore derived a dose-response model that theoretically can be extrapolated from high dose data to low doses of interest, for mixtures of carcinogens and non-carcinogens."

The researchers then developed a Bayesian mathematical technique to allow their model to accept various types of input information and produce a risk estimate that is rigorously more conservative the less information is available for the assessment.

"More generally, I hope to motivate others to study and apply the predictive Bayesian approach to dose-response assessment, which I strongly believe in as a basis for management of ever-progressing chemical technology and for microbial dose-response assessment as well."

The paper is titled "A Gradient Markov Chain Monte Carlo Algorithm for Computing Multivariate Maximum Likelihood Estimates and Posterior Distributions: Mixture Dose-Response Assessment." Co-authors are Ruochen Li, financial systems analyst, at the Hang Seng Bank, Shanghai, China and Xiaoguang Li, postdoctoral associate, at Fudan University, Shanghai, China.

Englehardt is now overseeing work on a method to detect risk in drinking water in real time, directly from sensor data. That work is part of a current project, sponsored by the National Science Foundation, to build an autonomous net-zero water residence hall on the University of Miami campus. All wastewater from the residence hall will be converted to drinking water, for return to the residence hall in a closed loop process. During the research, student residents will not drink or cook with the water, but will use it for all other purposes.
'/>"/>

Contact: Catharine Skipp
c.skipp@miami.edu
305-284-3667
University of Miami
Source:Eurekalert

Related medicine news :

1. Researchers identify potential target to delay metastatic pancreatic cancer and prolong survival
2. Researchers use light to measure cancer cells response to treatment
3. Boston University researcher awarded 2 NIH grants
4. MDC researchers: Ion channel makes African naked mole-rat insensitive to acid-induced pain
5. MU researchers find pet kidney injuries are similar to human kidney injuries
6. UC Irvine researchers urge caution when buying noisy toys
7. Ohio State researchers discover hereditary predisposition of melanoma of the eye
8. Psychology researcher finds that second-guessing ones decisions leads to unhappiness
9. Researchers investigate link between autoimmune diseases and wounds that dont heal
10. Researchers describe a new genetic program that converts static cells into mobile invasive cells
11. UIC researchers discover how cells limit inflammation in lung injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot on ... CIOReview. , In a deliberate session with the honorary industrial experts, a list of ... with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample Management ...
(Date:5/25/2016)... ... 25, 2016 , ... DKT International, one of the largest ... pleased to release their 2015 global impact data. In 2015, DKT served over ... deaths and 3.8 million unsafe abortions across 21 countries worldwide. , “We ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... ... ... more than fifty years, we've suffered whiplash as each new scientific study seemed to contradict ... nutritional advice – advice that was supposed to keep us healthy and slim. And what ... are considered to be overweight and more than 1 in 3 adults are considered to ...
(Date:5/25/2016)... ... 25, 2016 , ... Researchers from SUNY State College of Optometry won the ... visual evoked potential and human attention. The article, VEP and Human Attention: Translation ... ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to record ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology: